image
Healthcare - Medical - Healthcare Plans - NYSE - US
$ 53.19
-3.45 %
$ 66.9 B
Market Cap
13.3
P/E
1. INTRINSIC VALUE

CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Its Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals.[ Read More ]

The intrinsic value of one CVS stock under the base case scenario is HIDDEN Compared to the current market price of 53.2 USD, CVS Health Corporation is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart CVS

image
FINANCIALS
358 B REVENUE
11.24%
13.7 B OPERATING INCOME
-12.70%
8.37 B NET INCOME
100.91%
13.4 B OPERATING CASH FLOW
-17.01%
-20.9 B INVESTING CASH FLOW
-313.89%
2.68 B FINANCING CASH FLOW
125.51%
95.4 B REVENUE
4.49%
832 M OPERATING INCOME
-74.30%
71 M NET INCOME
-95.99%
-745 M OPERATING CASH FLOW
-24.12%
-3.35 B INVESTING CASH FLOW
-105.97%
-1.59 B FINANCING CASH FLOW
-127.14%
Balance Sheet Decomposition CVS Health Corporation
image
Current Assets 67.9 B
Cash & Short-Term Investments 11.5 B
Receivables 35.2 B
Other Current Assets 21.2 B
Non-Current Assets 182 B
Long-Term Investments 23 B
PP&E 30.4 B
Other Non-Current Assets 128 B
Current Liabilities 79.2 B
Accounts Payable 14.9 B
Short-Term Debt 4.71 B
Other Current Liabilities 59.6 B
Non-Current Liabilities 93.9 B
Long-Term Debt 90.7 B
Other Non-Current Liabilities 3.2 B
EFFICIENCY
Earnings Waterfall CVS Health Corporation
image
Revenue 358 B
Cost Of Revenue 303 B
Gross Profit 54.4 B
Operating Expenses 40.7 B
Operating Income 13.7 B
Other Expenses 5.38 B
Net Income 8.37 B
RATIOS
15.21% GROSS MARGIN
15.21%
3.84% OPERATING MARGIN
3.84%
2.33% NET MARGIN
2.33%
10.91% ROE
10.91%
3.34% ROA
3.34%
6.68% ROIC
6.68%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis CVS Health Corporation
image
Net Income 8.37 B
Depreciation & Amortization 4.37 B
Capital Expenditures -3.03 B
Stock-Based Compensation 588 M
Change in Working Capital 15 M
Others -453 M
Free Cash Flow 10.4 B
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets CVS Health Corporation
image
Wall Street analysts predict an average 1-year price target for CVS of $76.9 , with forecasts ranging from a low of $63 to a high of $100 .
CVS Lowest Price Target Wall Street Target
63 USD 18.44%
CVS Average Price Target Wall Street Target
76.9 USD 44.59%
CVS Highest Price Target Wall Street Target
100 USD 88.01%
4. DIVIDEND ANALYSIS
1.06% DIVIDEND YIELD
0.665 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership CVS Health Corporation
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
2.27 M USD 1
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
554 K USD 2
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
6 months ago
May 02, 2024
Bought 53.9 K USD
LUDWIG EDWARD J
Director
+ 1000
53.879 USD
6 months ago
May 02, 2024
Bought 500 K USD
Mahoney Michael F
Director
+ 9181
54.4923 USD
9 months ago
Feb 16, 2024
Sell 2.27 M USD
Shah Prem S
EVP and Pres-Pharm, Consumer W
- 29473
76.95 USD
1 year ago
Nov 03, 2023
Bought 141 K USD
LUDWIG EDWARD J
Director
+ 2000
70.465 USD
1 year ago
Aug 03, 2023
Sell 197 K USD
Clark James David
SVP, Cont & Chief Acct Officer
- 2631.255
74.79 USD
1 year ago
Aug 03, 2023
Sell 1.73 M USD
Clark James David
SVP, Cont & Chief Acct Officer
- 23128
74.94 USD
1 year ago
May 03, 2023
Bought 977 K USD
Lynch Karen S
President and CEO
+ 14000
69.7548 USD
1 year ago
Dec 15, 2022
Sell 3.58 M USD
Moriarty Thomas M
EVP & General Counsel
- 36490
98.2425 USD
2 years ago
Aug 03, 2022
Sell 6.9 M USD
Lotvin Alan
EVP&President-PharmacyServices
- 70398
98 USD
2 years ago
Aug 03, 2022
Sell 955 K USD
Finke Daniel P
EVP/Pres, Health Care Benefits
- 9546
100 USD
2 years ago
Jun 28, 2022
Sell 4.8 M USD
Moriarty Thomas M
EVP & General Counsel
- 50502
95 USD
2 years ago
Apr 08, 2022
Sell 600 K USD
Shah Prem S
EVP and Co-President of Retail
- 5719
105 USD
2 years ago
Apr 04, 2022
Sell 1.62 M USD
Finke Daniel P
EVP/Pres, Health Care Benefits
- 16161
100.13 USD
2 years ago
Mar 30, 2022
Sell 560 K USD
Shah Prem S
EVP and Co-President of Retail
- 5346
104.7 USD
2 years ago
Mar 17, 2022
Sell 313 K USD
Shah Prem S
EVP and Co-President of Retail
- 2935
106.65 USD
2 years ago
Mar 15, 2022
Sell 5.39 M USD
Moriarty Thomas M
EVP & General Counsel
- 51361
105 USD
2 years ago
Feb 10, 2022
Bought 106 K USD
LUDWIG EDWARD J
Director
+ 1000
105.9044 USD
2 years ago
Feb 10, 2022
Bought 106 K USD
LUDWIG EDWARD J
Director
+ 1000
105.9044 USD
2 years ago
Feb 03, 2022
Sell 5.27 M USD
Brennan Troyen A
EVP and Chief Medical Officer
- 47937
110 USD
2 years ago
Feb 01, 2022
Sell 2.28 M USD
Lotvin Alan
EVP&President-PharmacyServices
- 21386
106.498 USD
2 years ago
Jan 28, 2022
Sell 660 K USD
Clark James David
SVP, Cont & Chief Acct Officer
- 6059
109 USD
2 years ago
Jan 28, 2022
Sell 660 K USD
Clark James David
SVP, Cont & Chief Acct Officer
- 6059
109 USD
2 years ago
Jan 27, 2022
Sell 7.36 M USD
Roberts Jonathan C
EVP & Chief Operating Officer
- 68482
107.5 USD
3 years ago
Nov 03, 2021
Sell 10.3 M USD
Roberts Jonathan C
EVP & Chief Operating Officer
- 108870
95 USD
3 years ago
Nov 03, 2021
Sell 10.3 M USD
Roberts Jonathan C
EVP & Chief Operating Officer
- 108870
95 USD
3 years ago
Nov 01, 2021
Sell 2.53 M USD
Brennan Troyen A
EVP and Chief Medical Officer
- 28159
90 USD
3 years ago
Oct 26, 2021
Sell 172 K USD
Brennan Troyen A
EVP and Chief Medical Officer
- 1955
88 USD
3 years ago
Oct 26, 2021
Sell 7.11 M USD
Brennan Troyen A
EVP and Chief Medical Officer
- 80802
88 USD
3 years ago
Sep 02, 2021
Sell 228 K USD
Brennan Troyen A
EVP and Chief Medical Officer
- 2625
87 USD
3 years ago
Aug 05, 2021
Bought 239 K USD
LUDWIG EDWARD J
Director
+ 3000
79.545 USD
3 years ago
Jun 28, 2021
Sell 233 K USD
Lotvin Alan
EVP&President-PharmacyServices
- 2781
83.67 USD
3 years ago
Jun 15, 2021
Sell 5.81 M USD
Brennan Troyen A
EVP and Chief Medical Officer
- 67552
86 USD
3 years ago
Jun 07, 2021
Sell 3.26 M USD
Finke Daniel P
EVP/Pres, Health Care Benefits
- 37594
86.6 USD
3 years ago
May 10, 2021
Sell 9.41 M USD
Moriarty Thomas M
EVP & General Counsel
- 109469
86 USD
3 years ago
May 07, 2021
Sell 796 K USD
Brennan Troyen A
EVP and Chief Medical Officer
- 9477
84 USD
3 years ago
May 04, 2021
Sell 392 K USD
Boratto Eva C
EVP & CFO
- 4905
80 USD
3 years ago
Apr 21, 2021
Sell 7.78 M USD
Moriarty Thomas M
EVP & General Counsel
- 101003
77 USD
3 years ago
Apr 21, 2021
Sell 186 K USD
Moriarty Thomas M
EVP & General Counsel
- 2420
77 USD
3 years ago
Mar 31, 2021
Sell 407 K USD
Clark James David
SVP, Cont & Chief Acct Officer
- 5350
76 USD
3 years ago
Mar 29, 2021
Sell 4.79 M USD
Moriarty Thomas M
EVP & General Counsel
- 62943
76.15 USD
3 years ago
Mar 26, 2021
Sell 5.47 M USD
Roberts Jonathan C
EVP & Chief Operating Officer
- 73433
74.49 USD
3 years ago
Mar 26, 2021
Sell 20.2 M USD
MERLO LARRY J
Director
- 270650
74.73 USD
3 years ago
Mar 19, 2021
Sell 3.65 M USD
Moriarty Thomas M
EVP & General Counsel
- 49211
74.15 USD
3 years ago
Mar 16, 2021
Sell 1.41 M USD
Boratto Eva C
EVP & CFO
- 18882
74.68 USD
3 years ago
Feb 17, 2021
Bought 216 K USD
LUDWIG EDWARD J
Director
+ 3000
72 USD
3 years ago
Jan 19, 2021
Sell 4.84 M USD
MERLO LARRY J
President and CEO
- 62893
77 USD
3 years ago
Jan 12, 2021
Sell 1.94 M USD
Bisaccia Lisa
EVP and Chief HR Officer
- 25177
77 USD
3 years ago
Jan 08, 2021
Sell 1.94 M USD
Lotvin Alan
EVP and President-CVS Caremark
- 25836
75 USD
3 years ago
Jan 08, 2021
Sell 4.42 M USD
Brennan Troyen A
EVP and Chief Medical Officer
- 58896
75 USD
4 years ago
Nov 13, 2020
Sell 500 K USD
Lotvin Alan
EVP and President-CVS Caremark
- 7138
70 USD
4 years ago
Nov 10, 2020
Sell 1.5 M USD
Flum Joshua Matthew
EVP, ENT STRATEGY & DIGITAL
- 21460
70 USD
4 years ago
May 26, 2020
Sell 686 K USD
Mayhew Jonathan E.
EVP - Transformation
- 10556
65 USD
4 years ago
May 26, 2020
Sell 17.6 K USD
Clark James David
SVP, Cont & Chief Acct Officer
- 270
65 USD
4 years ago
May 11, 2020
Bought 316 K USD
Lotvin Alan
EVP and President-CVS Caremark
+ 5000
63.135 USD
4 years ago
Apr 28, 2020
Sell 405 K USD
Clark James David
SVP, Cont & Chief Acct Officer
- 6234
65 USD
4 years ago
Mar 30, 2020
Sell 182 K USD
Clark James David
SVP, Cont & Chief Acct Officer
- 3030
60 USD
4 years ago
Jan 15, 2020
Sell 19.9 M USD
MERLO LARRY J
President and CEO
- 266476
74.79 USD
4 years ago
Jan 08, 2020
Sell 4.18 M USD
Roberts Jonathan C
EVP & Chief Operating Officer
- 57563
72.63 USD
5 years ago
Nov 18, 2019
Sell 6.01 M USD
Lynch Karen S
EVP & Pres, Aetna Bus Unit
- 80143
75 USD
5 years ago
Nov 04, 2019
Sell 1.61 M USD
Brennan Troyen A
EVP and Chief Medical Officer
- 23604
68 USD
5 years ago
Sep 30, 2019
Sell 1.12 M USD
Flum Joshua Matthew
EVP, ENT STRATEGY & DIGITAL
- 17703
63 USD
5 years ago
Sep 12, 2019
Sell 528 K USD
Boratto Eva C
EVP & CFO
- 8130
65 USD
7. News
Glenview, Sachem Head, Third Point buy CVS shares during Q3-filings Three prominent investment firms bet changes are in the offing at ailing healthcare giant CVS Health and added to existing bets and established a new position during the third quarter, according to regulatory filings. reuters.com - 2 days ago
2 Beaten-Down Dividend Stocks to Buy and Hold They're down, but they aren't out, at least not in the eyes of patient investors. fool.com - 3 days ago
Is Trending Stock CVS Health Corporation (CVS) a Buy Now? Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects. zacks.com - 4 days ago
Estimates for CVS Southbound After Rocky Q3: How to Play the Stock CVS Health expects the elevated levels of utilization to continue to put pressure on its 2024 performance and as a result could not provide an outlook for 2024. zacks.com - 5 days ago
CVS Health to present at the Wolfe 2024 Healthcare Conference WOONSOCKET, R.I. , Nov. 11, 2024 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced that Chief Financial Officer Tom Cowhey will participate in a fireside chat with investors at the Wolfe 2024 Healthcare Conference on November 19, 2024, at approximately 10:20 am ET. prnewswire.com - 5 days ago
CVS Health Path Forward Becomes Clearer And Breakup Is Unlikely Cold water has been tossed on the idea that CVS Health would break up the company and sell off health or pharmacy benefits from assets that provide medical care if you listen closely to the company's new chief executive. forbes.com - 6 days ago
CVS Health: Is It Time For A Turnaround? CVS Health stock surged over 11% following a sizable revenue beat and the appointment of new CEO David Joyner, an industry veteran. The political landscape shift with Trump regaining the presidency and GOP gains is seen as a positive for CVS and Medicare Advantage stocks. Despite revenue growth, CVS faces significant challenges, including elevated medical costs and restructuring charges, impacting earnings and requiring a strategic turnaround. seekingalpha.com - 1 week ago
Could I Have Been Completely Wrong About CVS? Despite recent struggles, I remain bullish on CVS due to its potential for long-term growth and undervaluation, with a strong support level around $50. CVS faces challenges like high debt levels and declining margins, but restructuring efforts and improved star ratings offer reasons for optimism. The third quarter results showed revenue growth but significant declines in operating income and earnings per share, reflecting ongoing operational challenges. seekingalpha.com - 1 week ago
CVS earnings: Shares soar on mixed results CNBC's Bertha Coombs reports on news from CVS. youtube.com - 1 week ago
CVS Health Q3 Results Reflect Struggles in Digital Health Services Amid Strategic Overhaul CVS Health's third-quarter earnings results released Wednesday (Nov. 6) reflected the company's ongoing efforts to adapt to a changing healthcare and retail environment. As it continued to overhaul its operations in response to shifting market dynamics, including the digital transformation of healthcare, CVS faced challenges across its various business units. pymnts.com - 1 week ago
CVS Health Q3 Earnings & Revenues Beat, Stock Rises in Premarket CVS' third-quarter 2024 results reflect strong performance in the Health Services and Pharmacy & Consumer Wellness segments. zacks.com - 1 week ago
Gold Down Over 2%; CVS Health Shares Jump After Q3 Results U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 2% on Wednesday. benzinga.com - 1 week ago
8. Profile Summary

CVS Health Corporation CVS

image
COUNTRY US
INDUSTRY Medical - Healthcare Plans
MARKET CAP $ 66.9 B
Dividend Yield 1.06%
Description CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Its Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company's Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. As of December 31, 2021, it operated approximately 9,900 retail locations and 1,200 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
Contact One CVS Drive, Woonsocket, RI, 02895 https://www.cvshealth.com
IPO Date Nov. 20, 1996
Employees 219000
Officers Ms. Heidi B. Capozzi Executive Vice President & Chief People Officer Mr. Samrat S. Khichi Esq. Executive Vice President, Chief Policy Officer & General Counsel Mr. David A. Falkowski Executive Vice President & Chief Compliance Officer Mr. Tilak Mandadi Executive Vice President of Ventures and Chief Digital, Data, Analytics & Technology Officer Mr. J. David Joyner CEBS President, Chief Executive Officer & Director Mr. Thomas Francis Cowhey Executive Vice President & Chief Financial Officer Mr. Prem S. Shah Pharm.D Group President Dr. Joneigh S. Khaldun F.A.C.E.P., M.D., M.P.H. Vice President & Chief Health Equity Officer Mr. Vijay Patel Senior Director of Business Development & CVS Health and Partner & Co-Founder Mr. James David Clark Senior Vice President, Controller & Chief Accounting Officer